FoxP3 genetic variants and risk of non-small cell lung cancer in the Chinese Han population

被引:43
作者
He, Yan-Qi [1 ]
Bo, Qiao [2 ]
Yong, Wei [3 ]
Qiu, Zhi-Xin [1 ]
Li, Ya-Lun [1 ]
Li, Wei-Min [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610041, Sichuan, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing 400016, Peoples R China
[3] Seventh Peoples Hosp Chengdu, Dept Gen Surg, Chengdu 610021, Peoples R China
关键词
FoxP3; Lung cancer; Single nucleotide polymorphism; Cancer risk; REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; IPEX SYNDROME; EXPRESSION; DISEASE; ASSOCIATION; CARCINOMA; CLASSIFICATION; TRANSCRIPTION; SURVIVAL;
D O I
10.1016/j.gene.2013.08.066
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
CD4(+)CD25(+) regulatory T cell-mediated immunosuppression is one of the crucial mechanisms that tumor cells use to evade the immune system. The forkhead box P3 (FoxP3) gene regulates regulatory T-cell development and function and may modulate the susceptibility to non-small cell lung cancer (NSCLC). Because a single nucleotide polymorphism (SNP) within the FoxP3 gene (rs3761548 in the promoter region) is associated with susceptibility to Graves' disease, this study detected rs3761548 in a hospital-based case-control study. A total of 192 NSCLC patients and 259 healthy subjects were recruited for the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis of FoxP3 SNP. The data showed that the A allele of rs3761548 significantly increased NSCLC risk (P = 0.000, OR = 2.32, 95%CI = 1.736-3.102). The AC genotype, AA genotype, and the combined A variant genotype (AA + AC) were also associated with a higher risk of NSCLC (OR [95%CI] = 2.147 [1.419-3.247], 4.413[2.359-8.255], and 2.563[1.746-3.761], respectively). Moreover, a significantly higher frequency of AA + AC genotype was obsenred in patients with stage II NSCLC (OR, 2.053; 95%CI, 1.033-4.078). In conclusion, the data from the current study demonstrated for the first time the association of the FoxP3 SNP with a risk of developing NSCLC in the Chinese Han population. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:422 / 425
页数:4
相关论文
共 44 条
  • [11] Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer
    Hinz, Sebastian
    Pagerols-Raluy, Laia
    Oberg, Hans-Heinrich
    Ammerpohl, Ole
    Gruessel, Sandra
    Sipos, Bence
    Gruetzmann, Robert
    Pilarskys, Christian
    Ungefroren, Hendrik
    Saeger, Hans-Detlev
    Mloeppel, Guenter
    Kabelitz, Dieter
    Kalthoff, Holger
    [J]. CANCER RESEARCH, 2007, 67 (17) : 8344 - 8350
  • [12] Holtta Veera, 2012, ISRN Gastroenterol, V2012, P505432, DOI 10.5402/2012/505432
  • [13] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061
  • [14] CD8+CD28-cells and CD4+CD25+regulatory T cells in the peripheral blood of advanced stage lung cancer patients
    Karagoz, Bulent
    Bilgi, Oguz
    Gumus, Mahmut
    Erikci, Alev Akyol
    Sayan, Ozkan
    Turken, Orhan
    Kandemir, Emin Goekhan
    Ozturk, Ahmet
    Yaylaci, Mustafa
    [J]. MEDICAL ONCOLOGY, 2010, 27 (01) : 29 - 33
  • [15] Foxp3 expression in human cancer cells
    Karanikas, Vaios
    Speletas, Matthaios
    Zamanakou, Maria
    Kalala, Fani
    Loules, Gedeon
    Kerenidi, Theodora
    Barda, Angeliki K.
    Gourgoulianis, Konstantinos I.
    Germenis, Anastasios E.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [16] Signalling through FOXP3 as an X-linked tumor suppressor
    Katoh, Hiroto
    Zheng, Pan
    Liu, Yang
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (11) : 1784 - 1787
  • [17] An essential role for Scurfin in CD4+CD25+ T regulatory cells
    Khattri, R
    Cox, T
    Yasayko, SA
    Ramsdell, F
    [J]. NATURE IMMUNOLOGY, 2003, 4 (04) : 337 - 342
  • [18] CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers
    Kono, Koji
    Kawaida, Hiromichi
    Takahashi, Akihiro
    Sugai, Hidemitsu
    Mimura, Kosaku
    Miyagawa, Naoto
    Omata, Hideo
    Fujii, Hideki
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (09) : 1064 - 1071
  • [19] DNA ADDUCTS AS A MEASURE OF LUNG-CANCER RISK IN HUMANS EXPOSED TO POLYCYCLIC AROMATIC-HYDROCARBONS
    KRIEK, E
    VANSCHOOTEN, FJ
    HILLEBRAND, MJX
    VANLEEUWEN, FE
    DENENGELSE, L
    DELOOFF, AJA
    DIJKMANS, APG
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 99 : 71 - 75
  • [20] Li Wei-Ying, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P1042